This compound is a synthetic nucleoside analog intermediate featuring a benzamide-substituted pyrimidine base linked to a modified ribose sugar. It is primarily used in the pharmaceutical manufacturing of nucleotide-based therapeutics.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 340162-93-8
N-Benzoyl-2'-O-methoxyethyl-5-O-dimethoxytrityl-5-methylcytidine
pharmaceutical intermediate
N-Benzoyl-2'-O-(2-methoxyethyl)adenosine
pharmaceutical intermediate
2-Amino-6-fluoropurine
pharmaceutical intermediate
2-(Hydroxymethyl)-6-imino-7-methyl-2,3,3a,9a-tetrahydro-6H-furo[2',3':4,5][1,3]oxazolo[3,2-a]pyrimidin-3-ol--hydrogen chloride (1/1)
pharmaceutical intermediate
4,6-Dichloro-1-(2,3,5-tri-O-acetyl-beta-L-ribofuranosyl)-1H-imidazo[4,5-c]pyridine
pharmaceutical intermediate
5-(4-Chlorophenyl)furfural
pharmaceutical intermediate
3,4-Difluorobenzaldehyde
pharmaceutical intermediate
(4S)-4-[(4-Hydroxyphenyl)methyl]-2,5-oxazolidinedione
pharmaceutical intermediate
N-[1-[(2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-(2-methoxyethoxy)oxolan-2-yl]-5-methyl-2-oxopyrimidin-4-yl]benzamide
LGGHYGUGIGYDFX-YKTARERQSA-N
CC1=CN(C(=O)N=C1NC(=O)C2=CC=CC=C2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)OCCOC
—